Literature DB >> 20524156

Graft survival and complications after laparoscopic gastric banding for morbid obesity--lessons learned from a 12-year experience.

Markus Naef1, Wolfgang G Mouton, Ursula Naef, Oliver Kummer, Beat Muggli, Hans E Wagner.   

Abstract

Laparoscopic adjustable gastric banding (LAGB) has been considered by many as the treatment of choice for morbid obesity because of its simplicity and encouraging early results. The aim of this prospective study was to critically assess the effects, complications, and outcome after LAGB in the long-term, based on a 12-year experience. Between June 1998 and June 2009, all patients with implantation of a LAGB have been enrolled in a prospective clinical trial. Results were recorded and classified, with special regard to long-term complications, re-operation rate, and graft survival. LAGB was performed in 167 patients (120 female, 47 male) with a mean age of 40.1 +/- 5.2 years. Operative mortality was 0%, overall 1.2% (not band-related). Overall patient follow-up was 94.0%. Mean excess weight loss (EWL) after 1, 2, 5, 8, and 10 years was 31.1 +/- 7.5% (p < 0.005), 44.2 +/- 6.5% (p < 0.001), 50.3 +/- 6.9% (p < 0.001), 51.7 +/- 6.3% (p < 0.001), and 48.8 +/- 6.0% (p < 0.001), respectively. The non-responder rate (EWL < 30%) after 2, 5, 8, and 10 years was 24.5%, 18.3%, 12.5%, and 16.6%, respectively. The early complication rate (<30 days) was 7.8% (13/167), with 10 minor and three major complications. Late complications (>30 days) occurred in 40.1% (67/167), of whom seven were minor and 60 were major complications (three band infections, two band migrations, 11 band leakages, two slippings/pouch dilatations, two band intolerances, and 40 esophageal dilatations). The overall re-operation rate was 20.4% (34/167). The graft survival of the implanted band after 2, 5, 8, 10, and 12 years was 98.8%, 94.0%, 86.8%, 85.0%, and 85.0%, respectively. The failure rate of the procedure after 2, 5, 8, and 10 years was 25.7%, 24.3%, 25.7%, and 31.6%, respectively. In the present long-term high-participation follow-up study, LAGB is a safe and effective surgical treatment for morbid obesity. However, the high complication, re-operation, and long-term failure rates lead to the conclusion that LAGB should be performed in selected cases only, until reliable criteria for patients at low risk for long-term complications are developed.

Entities:  

Mesh:

Year:  2010        PMID: 20524156     DOI: 10.1007/s11695-010-0205-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  68 in total

1.  The technical approach in banding to avoid pouch dilatation.

Authors:  B Elias; J P Staudt; E Van Vyne
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

2.  Surgical treatment of severe obesity with a low-pressure adjustable gastric band: experimental data and clinical results in 625 patients.

Authors:  Wim Ceelen; Jean Walder; Anne Cardon; Katrien Van Renterghem; Uwe Hesse; Mohamed El Malt; Piet Pattyn
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

Review 3.  Surgery for morbid obesity: selection of operation based on evidence from literature review.

Authors:  Carlos Manterola; Viviana Pineda; Manuel Vial; Héctor Losada; Sergio Muñoz
Journal:  Obes Surg       Date:  2005-01       Impact factor: 4.129

4.  Prevention of pouch dilatation after laparoscopic adjustable gastric banding.

Authors:  Marco Antonio Zappa; Giancarlo Micheletto; Ezio Lattuada; Enrico Mozzi; Alessandra Spinola; Massimo Meco; Giancarlo Roviaro; Santo Bressani Doldi
Journal:  Obes Surg       Date:  2006-02       Impact factor: 4.129

5.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

6.  Laparoscopic adjustable gastric band versus laparoscopic Roux-en-Y gastric bypass: ends justify the means?

Authors:  C Galvani; M Gorodner; F Moser; M Baptista; C Chretien; R Berger; S Horgan
Journal:  Surg Endosc       Date:  2006-05-11       Impact factor: 4.584

7.  A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates.

Authors:  M Suter; J M Calmes; A Paroz; V Giusti
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  Outcome and complications after laparoscopic Swedish adjustable gastric banding: 5-year results of a prospective clinical trial.

Authors:  Markus Naef; Ursula Naef; Wolfgang G Mouton; Hans E Wagner
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

10.  The effect of laparoscopic adjustable gastric bands on esophageal motility and the gastroesophageal junction: analysis using high-resolution video manometry.

Authors:  Paul R Burton; Wendy Brown; Cheryl Laurie; Melissa Richards; Sohail Afkari; Kenneth Yap; Anna Korin; Geoff Hebbard; Paul E O'Brien
Journal:  Obes Surg       Date:  2009-05-08       Impact factor: 4.129

View more
  19 in total

Review 1.  The reporting of gastric band slip and related complications; a review of the literature.

Authors:  Richard John Egan; Simon J W Monkhouse; Hayley E Meredith; Sharon E Bates; Justin D T Morgan; Sally A Norton
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

2.  Laparoscopic Adjustable Gastric Banding in Australian Adolescents: Should It Be Done?

Authors:  Alexia Sophie Peña; Tarik Delko; Richard Couper; Kerri Sutton; Stamatiki Kritas; Taher Omari; Jacob Chisholm; Lilian Kow; Sanjeev Khurana
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

3.  Revisional versus primary Roux-en-Y gastric bypass: a case-matched analysis.

Authors:  Tarik Delko; Thomas Köstler; Miroslav Peev; Adrian Esterman; Daniel Oertli; Urs Zingg
Journal:  Surg Endosc       Date:  2013-10-03       Impact factor: 4.584

4.  Endoscopic management of penetrated adjustable gastric band with its connecting tube: report of a case.

Authors:  Halil Coskun; Suleyman Bozkurt; Tuba Atak; Huseyin Kadioglu
Journal:  Obes Facts       Date:  2011-06-14       Impact factor: 3.942

5.  The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults.

Authors:  Mahdieh Golzarand; Karamollah Toolabi; Roya Farid
Journal:  Surg Endosc       Date:  2017-04-04       Impact factor: 4.584

Review 6.  How to Choose the Best Metabolic Procedure?

Authors:  Lidia Castagneto Gissey; James Rossario Casella Mariolo; Geltrude Mingrone
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113

7.  A 5-year experience of laparoscopic adjustable gastric banding in China.

Authors:  Qiaojun Han; Yue Chen; Jianbing Zhuge; Zhaolong Zhang; Dajin Zou
Journal:  Obes Surg       Date:  2013-02       Impact factor: 4.129

8.  Primary sleeve gastrectomy compared to sleeve gastrectomy as revisional surgery: weight loss and complications at intermediate follow-up.

Authors:  Allison M Barrett; Kim T Vu; Kulmeet K Sandhu; Edward H Phillips; Scott A Cunneen; Miguel A Burch
Journal:  J Gastrointest Surg       Date:  2014-08-14       Impact factor: 3.452

9.  Long-Term Outcomes of the Laparoscopic Adjustable Gastric Banding: Weight Loss and Removal Rate. A Single Center Experience on 301 Patients with a Minimum Follow-Up of 10 years.

Authors:  Sergio Carandina; Malek Tabbara; Leila Galiay; Claude Polliand; Daniel Azoulay; Christophe Barrat; Andrea Lazzati
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

10.  Long-Term Results After Laparoscopic Adjustable Gastric Banding for Morbid Obesity: 18-Year Follow-Up in a Single University Unit.

Authors:  K Arapis; P Tammaro; L Ribeiro Parenti; A L Pelletier; D Chosidow; M Kousouri; C Magnan; B Hansel; J P Marmuse
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.